Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Dare Bioscience, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 23 | 21 | −2 |
| Shares | 904.3K | 1.01M | +104.9K (+11.6%) |
| Value | $2.16M | $2.12M | −$42.9K (−2.0%) |
New holders (4)
Institutions that held Dare Bioscience, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 17,740 | $37.0K | 0.00% |
| HighTower Advisors, LLC | 11,692 | $24.6K | 0.00% |
| Mather Group, LLC. | 84 | $176 | 0.00% |
| Citigroup Inc | 2 | $4 | 0.00% |
Sold out (6)
Institutions that held Dare Bioscience, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Commonwealth Equity Services, LLC | 16,735 | $40.0K |
| Allworth Financial LP | 1,667 | $3.98K |
| Tower Research Capital LLC (TRC) | 1,440 | $3.44K |
| EverSource Wealth Advisors, LLC | 42 | $100 |
| Morgan Stanley | 7 | $17 |
| Putney Financial Group LLC | 1 | $2 |